Thyroid Potency Calculations
Download in electronic PDF format for $75
Abstract: The United States Pharmacopeia defines the label strength for Levothyroxine Sodium USP, Liothyronine Sodium USP, and Thyroid Powder USP. These powders need a certificate of analysis for potency calculations. This article is an explanation of the calculations involved to achieve the correct United States Pharmacopeia label strength for thyroid hormones.
Related Keywords:
thyroid hormones T4 T3, levothyroxine sodium, liothyronine sodium, certificates of analysis, thyroid USP, potency analysis
| Related Articles from IJPC |
Title/Author
(Click for Abstract / Details / Purchase) |
Issue/Page
View/Buy |
Thyroid Potency Calculations
Stack Bob
|
Jul/Aug 2010
Pg. 306-309
|
Kinetic Analysis of Drug Release from Compounded Slow-release Capsules of Liothyronine Sodium (T3)
Bakhteyar Hamid, Cassone Clayton, Kohan Hamed Gilzad, Sani Shabnam N
|
Sep/Oct 2017
Pg. 418-425
|
Bioidentical Thyroid Replacement Therapy in Practice: Delivering a Physiologic T4-T3 Ratio for Improved Patient Outcomes with the Listecki-Snyder Protocol
Snyder Scott, Listecki Robert E
|
Sep/Oct 2012
Pg. 376-380
|
The U.S. Food and Drug Administration Takes Aim at Compounded Thyroid Hormone
Brunner Scott
|
Jan/Feb 2023
Pg. 22-23
|
Liothyronine Sodium (T3) 5-mcg/Hydrocortisone 5-mg Slow-Release Capsules
Allen Loyd V Jr
|
Nov/Dec 2008
Pg. 545
|
Liothyronine Sodium (T3) 5-mcg/Selenium 100-mcg Slow-Release Capsules
Allen Loyd V Jr
|
Nov/Dec 2008
Pg. 547
|
Liothyronine Sodium (T3) 5-mcg Slow-Release Capsules
Allen Loyd V Jr
|
Nov/Dec 2008
Pg. 548
|
Liothyronine Sodium (T3) 5-mcg/0.1-mL Transdermal Cream
Allen Loyd V Jr
|
Nov/Dec 2008
Pg. 546
|
Hypothyroidism: Optimizing Therapy with Slow-Release Compounded Thyroid Replacement
Milner Martin
|
Jul/Aug 2005
Pg. 268-273
|
Using Serum Hormone Analysis to Develop Hormone Replacement Therapy Regimens - Part 2
Ford Gina, Garcia Lea
|
Jan/Feb 2001
Pg. 52-54
|
Basics of Compounding with Dilutions and Concentrates
Allen Loyd V Jr
|
Jan/Feb 2017
Pg. 39-45
|
Quality Control: Analytical Methods: Why Do I Need a Certificate of Analysis?
Zolner William J
|
May/Jun 2012
Pg. 226-229
|
Levothyroxine Sodium 100-mcg Capsules
Allen Loyd V Jr
|
Nov/Dec 2013
Pg. 505
|
Levothyroxine Sodium 40-micro-g/mL Oral Liquid
Allen Loyd V Jr
|
May/Jun 2007
Pg. 247
|
Solid State Stability of Extemporaneously Prepared Levothyroxine Aliquots and Capsules
Fortner Jeff, Salton Jason, Carlson Christie, Wheeler Rich, Cote Brianna, Rao Deepa
|
Sep/Oct 2015
Pg. 414-419
|
The Role of Sex Hormones on Fibromyalgia Pain Mediators
Bramwell Bethany L
|
May/Jun 2010
Pg. 193-199
|
Basics of Compounding: Basics of Compounding with Potency Designated Ingredients
Allen Loyd V Jr
|
Jan/Feb 2011
Pg. 56-61
|
Differentiation and Treatment of Hypothyroidism, Functional Hypothyroidism, and Functional Metabolism
Paoletti Jim
|
Nov/Dec 2008
Pg. 488-497
|
Differentiation and Treatment of Hypothyroidism, Functional Hypothyroidism, and Functional Metabolism
Paoletti Jim
|
Jan/Feb 2024
Pg. 34-43
|
Quality-Control Analytical Methods: Stability Versus Potency Testing: The Madness is in the Method
Kupiec Thomas C, Skinner Rodney, Lanier Lance
|
Jan/Feb 2008
Pg. 50-53
|
| Return to Top |
